Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Neuroblastoma 16Central Nervous System Neoplasms 13Brain Neoplasms 9Medulloblastoma 8Rhabdoid Tumor 6Astrocytoma 6Sarcoma 5Glioma 5Oligodendroglioma 4Lymphoma 4Pinealoma 3Osteosarcoma 3Optic Nerve Glioma 3Ependymoma 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Spinal Cord Neoplasms 2Rhabdomyosarcoma 2Recurrence 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Glioblastoma 2Ganglioneuroblastoma 2Familial ependymoma 2Drug-Related Side Effects and Adverse Reactions 2Choroid Plexus Neoplasms 2

Interventions

Thrombopoietin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Carboplatin 2sodium thiosulfate 1romiplostim 1pegfilgrastim 1etoposide phosphate 1Temozolomide 1Rituximab 1Radiotherapy 1Ifosfamide 1Cytarabine 1Cyclophosphamide 1Comparative Genomic Hybridization 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × etoposide phosphate × CNS × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡